Momesone Special Precautions

For topical use only; not for oral, ophthalmic, or intravaginal use. Avoid use on the face, groin, or axillae.
Systemic absorption of topical corticosteroids can produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression with the potential for glucocorticosteroid insufficiency after withdrawal of treatment. Manifestations of Cushing's syndrome, hyperglycemia, and glucosuria can also be produced in some patients by systemic absorption of topical corticosteroids while on treatment. Patients applying a topical steroid to a large surface area or areas under occlusion should be evaluated periodically for evidence of HPA axis suppression. Recovery of HPA-axis function is generally prompt and complete following discontinuance of drug.
If skin irritation occurs during topical corticosteroid therapy, the drug should be discontinued and appropriate therapy initiated.
In the presence of dermatological infection, use of the appropriate antifungal or antibacterial agent should be instituted. If a favorable response does not occur promptly, the corticosteroid should be discontinued until the infection is adequately controlled.
Any of the side effects that are reported following systemic use of corticosteroids, including adrenal suppression, may also occur with topical corticosteroids, especially in infants and children.
If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes of visual disturbances which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids.
Pediatric patients may be more susceptible to topical corticosteroid-induced HPA-axis suppression and Cushing's syndrome than mature individuals because of a greater skin surface area-to-body weight ratio.
MOMESONE (CREAM 0.1%) is not for ophthalmic use. Avoid contact with eyes. When applied to the eyelids or skin near the eyes because of the risk of cataract and glaucoma.